| 000 | 01756 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516184212.0 | ||
| 264 | 0 | _c20140527 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1502-7732 | ||
| 024 | 7 |
_a10.3109/03009742.2013.834964 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeregård, P | |
| 245 | 0 | 0 |
_aEtanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bScandinavian journal of rheumatology _c2014 |
||
| 300 |
_a85-90 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xpharmacology |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aArthroscopy |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImage Processing, Computer-Assisted |
| 650 | 0 | 4 |
_aImmunoglobulin G _xpharmacology |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aLymphotoxin-alpha _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aSynovial Membrane _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aKrishnamurthy, A | |
| 700 | 1 | _aRevu, S | |
| 700 | 1 | _aEngström, M | |
| 700 | 1 | _aaf Klint, E | |
| 700 | 1 | _aCatrina, A I | |
| 773 | 0 |
_tScandinavian journal of rheumatology _gvol. 43 _gno. 2 _gp. 85-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/03009742.2013.834964 _zAvailable from publisher's website |
| 999 |
_c23343706 _d23343706 |
||